BETA-ADRENORECEPTOR-BLOCKING AGENTS AND LIPID-METABOLISM

被引:33
作者
ENGLAND, JDF [1 ]
HUA, ASP [1 ]
SHAW, J [1 ]
机构
[1] UNIV MELBOURNE, ROYAL MELBOURNE HOSP, DEPT MED, MELBOURNE 3050, VICTORIA, AUSTRALIA
来源
CLINICAL SCIENCE AND MOLECULAR MEDICINE | 1978年 / 55卷
关键词
D O I
10.1042/cs055323s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S323 / S324
页数:2
相关论文
共 4 条
[1]   GLUCAGON LEVELS IN NORMAL AND DIABETIC SUBJECTS - USE OF A SPECIFIC IMMUNOABSORBENT FOR GLUCAGON RADIOIMMUNOASSAY [J].
ALFORD, FP ;
BLOOM, SR ;
NABARRO, JDN .
DIABETOLOGIA, 1977, 13 (01) :1-6
[2]   ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION [J].
AMES, RP ;
HILL, P .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :748-757
[3]   EFFECT OF CHRONIC ADMINISTRATION OF PROPRANOLOL ON LIPOPROTEIN COMPOSITION [J].
TANAKA, N ;
SAKAGUCHI, S ;
OSHIGE, K ;
NIIMURA, T ;
KANEHISA, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (10) :1071-1075
[4]   METABOLIC EFFECTS OF BETA-ADRENORECEPTOR BLOCKERS [J].
WAALMANNING, HJ .
DRUGS, 1976, 11 :121-126